Rapid detection of mutations in the p53 gene

• US 5,843,654 A
• Filed: 06/07/1995
• Issued: 12/01/1998
• Est. Priority Date: 12/07/1992
• Status: Expired due to Term

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Third Wave Technologies Incorporated (Hologic Incorporated)
• Inventors: Heisler, Laura M., Brow, Mary Ann D., Fors, Lance
• Primary Examiner(s): Patterson, Jr., Charles L.
• Application Number:
  US08/484,956
• Time in Patent Office: 1,273 Days
• Field of Search: 435/91.1, 435/199, 435/6, 435/18
• US Class Current: 435/6.14
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C07K 14/4746 p53
• CPC Class Codes: C07K 14/82 Translation products from oncogenes
• CPC Class Codes: C12N 15/10 Processes for the isolation, preparation or purification of DNA or RNA chemical preparation of DNA or RNA C07H21/00; preparation of non-structural polynucleotides from microorganisms or with enzymes C12P19/34
• CPC Class Codes: C12N 15/113 Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing when used in plants C12N15/8218
• CPC Class Codes: C12N 9/1252 DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
• CPC Class Codes: C12Q 1/682 Signal amplification
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 1/6886 for cancer immunoassay for cancer G01N33/574
• CPC Class Codes: C12Q 2521/301 Endonuclease
• CPC Class Codes: C12Q 2521/319 Exonuclease
• CPC Class Codes: C12Q 2525/301 Hairpin oligonucleotides
• CPC Class Codes: C12Q 2527/101 Temperature
• CPC Class Codes: C12Q 2537/149 Sequential reactions
• CPC Class Codes: C12Q 2563/137 Metal/ion, e.g. metal label

Abstract

The present invention relates to means for cleaving a nucleic acid cleavage structure in a site-specific manner. Enzymes, including 5'"'"' nucleases and 3'"'"' exonucleases, are used to screen for known and unknown mutations, including single base changes, in the human p53 gene. Methods are provided which allow for the identification of genetic mutations in the human p53 gene in a sample.

Claims

1. A method for treating nucleic acid comprising an oligonucleotide containing human p53 gene sequences, comprising:

a) providing;

i) an enzymatic cleavage means; and

ii) a nucleic acid substrate containing human p53 gene sequences;

b) treating said nucleic acid substrate under conditions such that said substrate forms one or more cleavage structures, said cleavage structures formed by intra-strand hydrogen bonding in the absence of a primer oligonucleotide; and

c) reacting said cleavage means with said cleavage structures so that a plurality of cleavage products are produced.

2. The method of claim 1, wherein said enzymatic cleavage means is a nuclease.

3. The method of claim 2, wherein said nuclease is selected from the group consisting of Cleavase™

BN nuclease, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and the Saccharomyces cerevisiae Rad1/Rad10 complex.

4. The method of claim 1, wherein said nucleic acid of step (a) is substantially single-stranded.

5. The method of claim 1, wherein said nucleic acid is RNA.

6. The method of claim 1, wherein said nucleic acid is DNA.

7. The method of claim 1, wherein said nucleic acid of step (a) is double stranded.

8. The method of claim 7, wherein said treating of step (b) comprises:

i) rendering said double-stranded nucleic acid substantially single-stranded; and

ii) exposing said single-stranded nucleic acid to conditions such that said single-stranded nucleic acid has secondary structure.

9. The method of claim 8, wherein said double-stranded nucleic acid is rendered substantially single-stranded by increased temperature.

10. The method of claim 1, further comprising the step of detecting said plurality of cleavage products.

11. A method, comprising:

a) providing

i) an enzymatic cleavage means in a solution containing manganese; and

ii) a nucleic acid substrate containing human p53 gene sequences;

b) treating said nucleic acid substrate with increased temperature such that said substrate is substantially single-stranded;

c) reducing said temperature under conditions such that said single-stranded substrate forms one or more cleavage structures, said cleavage structures formed by intra-strand hydrogen bonding in the absence of a primer oligonucleotide;

d) reacting said cleavage means with said cleavage structures so that a plurality of cleavage products are produced; and

e) detecting said plurality cleavage products.

12. The method of claim 11, wherein said enzymatic cleavage means is a nuclease.

13. The method of claim 12, wherein said nuclease is selected from the group consisting of Cleavase™

BN nuclease, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and the Saccharomyces cerevisiae Rad1/Rad10 complex.

14. The method of claim 11, wherein said nucleic acid is RNA.

15. The method of claim 11, wherein said nucleic acid is DNA.

16. The method of claim 11, wherein said nucleic acid of step (a) is double stranded.

17. A method for treating nucleic acid, comprising:

a) providing

i) an enzymatic cleavage means in a solution containing manganese; and

ii) a nucleic acid substrate containing human p53 gene sequences, said nucleic acid substrate comprising exons 5-8 of the human p53 gene;

b) treating said nucleic acid substrate with increased temperature such that said substrate is substantially single-stranded;

c) reducing said temperature under conditions such that said single-stranded substrate forms one or more cleavage structures, said cleavage structures formed by intra-strand hydrogen bonding in the absence of a primer oligonucleotide;

d) reacting said cleavage means with said cleavage structures so that one or more cleavage products are produced; and

e) detecting said one or more cleavage products.

18. The method of claim 17, wherein said enzymatic cleavage means is a nuclease.

19. The method of claim 18, wherein said nuclease is selected from the group consisting of Cleavase™

BN nuclease, Thermus aquaticus DNA polymerase, Thermus thermophilus DNA polymerase, Escherichia coli Exo III, and the Saccharomyces cerevisiae Rad1/Rad10 complex.

20. The method of claim 17, wherein said nucleic acid is RNA.

21. The method of claim 17, wherein said nucleic acid is DNA.

22. The method of claim 17, wherein said nucleic acid of step (a) is double stranded.

23. A method for detecting mutation in the human p53 gene, comprising:

a) providing;

i) an enzymatic cleavage means;

ii) a test nucleic acid substrate containing human p53 gene sequences; and

iii) control cleavage products produced by cleavage of a reference p53 gene sequence;

b) treating said test nucleic acid substrate under conditions such that said test substrate forms one or more cleavage structures;

c) reacting said cleavage means with said cleavage structures so that a plurality of test cleavage products are produced; and

d) comparing said test cleavage products to said control cleavage products.

24. The method of claim 23 wherein said cleavage products produced by cleavage of a reference p53 gene sequence are generated by the cleavage of a nucleic acid substrate containing the human p53 gene sequences selected from the group consisting of SEQ ID NOS:

92-94, 97-102 and 107-110.

25. The method of claim 23, wherein said test nucleic acid substrate containing human p53 gene sequences of step (a) is provided using the polymerase chain reaction.